Escalier Biosciences is developing both topical and oral RORγt inverse agonists for the treatment of a broad spectrum of psoriasis patients – from the underserved mild-to-moderate patients that would benefit from a safe and effective topical RORγt therapeutic to the more moderate-to-severe patients that would benefit from a safe and effective oral RORγt drug in lieu of injectable biologic therapies targeting IL-17 and IL-23.

Biotechnology

Education

Escalier Biosciences

Raju Mohan

Edward Van Wezel

Chris Krueger

John Nuss

The founding team at Escalier Biosciences has a history of working in various bioscience companies as CEOs and directors. They also have a background in chemistry, with degrees from the Indian Institute of Technology and the University of Illinois Urbana-Champaign.

Founding Team

Board of Directors

CEO and Executive Team

Leadership Team

Founding Team

About

Team members

Other teams at Escalier Biosciences

Board of Directors

CEO and Executive Team

Leadership Team